| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| Black Diamond Therapeutics Inc | |
|---|---|
| Ticker | BDTX |
| CIK # | 0001701541 |
| CUSIP | 09203E105 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 139 Main Street, Cambridge, MA 02142 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Black Diamond Therapeutics Inc | 2019-12-06 | 85.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| ASET Therapeutics Inc | 2017-03-28 | 12.1 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001701541] | 10-K | |
| [0001701541] | 10-Q | |
| [0001701541] | 3 | |
| [0001701541] | 4 | |
| [0001701541] | 8-K | |
| [0001701541] | D | |
| [0001701541] | SC 13D | |
| [0001701541] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Behbahani Ali
Common Stock
|
2026-03-20 | Grant | 6,919 | $2.15 | 14,876 |
|
Raman Prakash
Common Stock
|
2026-03-20 | Grant | 6,105 | $2.15 | 13,126 |
|
Yurasov Sergey
Stock Option (Right to Buy) · derivative
|
2026-01-21 | Grant | 250,000 | $0.00 | |
|
Hatzis-Schoch Brent
Stock Option (Right to Buy) · derivative
|
2026-01-21 | Grant | 250,000 | $0.00 | |
|
Buck Elizabeth
Stock Option (Right to Buy) · derivative
|
2026-01-21 | Grant | 250,000 | $0.00 | |
|
Jones Erika
Stock Option (Right to Buy) · derivative
|
2026-01-21 | Grant | 200,000 | $0.00 | |
|
Velleca Mark A
Stock Option (Right to Buy) · derivative
|
2026-01-21 | Grant | 600,000 | $0.00 | |
|
Raman Prakash
Common Stock
|
2025-12-12 | Grant | 4,665 | $2.76 | 12,875 |
|
Behbahani Ali
Common Stock
|
2025-12-12 | Grant | 5,208 | $2.76 | 14,374 |
|
Common Stock
|
2025-09-19 | Grant | 4,291 | $3.35 | 14,375 |
|
Common Stock
|
2025-09-19 | Grant | 3,843 | $3.35 | 12,874 |
|
Behbahani Ali
Common Stock
|
2025-06-20 | Grant | 6,170 | $2.33 | 14,376 |
|
Raman Prakash
Common Stock
|
2025-06-20 | Grant | 5,526 | $2.33 | 12,876 |
|
Kulkarni Samarth
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 30,550 | $0.00 | |
|
Campbell Shannon
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 30,550 | $0.00 | |
|
Behbahani Ali
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 30,550 | $0.00 | |
|
Raman Prakash
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 30,550 | $0.00 | |
|
Dhingra Kapil
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 30,550 | $0.00 | |
|
Menzel Garry E
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 30,550 | $0.00 | |
|
Raman Prakash
Common Stock
|
2025-03-21 | Grant | 6,848 | $1.88 | 12,874 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 104 | 25,774,305 |
| 2025-12-31 | 105 | 25,987,431 |
| 2025-09-30 | 92 | 28,116,608 |
| 2025-06-30 | 95 | 28,205,538 |
| 2025-03-31 | 88 | 30,457,429 |
| 2024-12-31 | 90 | 37,520,198 |
| 2024-09-30 | 104 | 40,911,326 |
| 2024-06-30 | 92 | 36,260,494 |
| 2024-03-31 | 89 | 32,749,719 |
| 2023-12-31 | 78 | 35,059,401 |
| 2023-09-30 | 74 | 35,256,399 |
| 2023-06-30 | 76 | 41,852,587 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Diversified Trust Co | [2026-06-30] | SOLE | 0 | 18,860 |
| DLK Investment Management LLC | [2026-06-30] | SOLE | 16,215 | 16,215 |
| Brookstone Capital Management | [2026-06-30] | SOLE | 0 | 13,484 | Prev | Page 1 | Next |